Literature DB >> 31562822

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.

Mary V Relling1, Teri E Klein2, Roseann S Gammal1,3, Michelle Whirl-Carrillo2, James M Hoffman1,4, Kelly E Caudle1.   

Abstract

In 2009, the Clinical Pharmacogenetics Implementation Consortium (CPIC, www.cpicpgx.org), a shared project between Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) and the National Institutes of Health (NIH), was created to provide freely available, evidence-based, peer-reviewed, and updated pharmacogenetic clinical practice guidelines. To date, CPIC has published 23 guidelines (of which 11 have been updated), covering 19 genes and 46 drugs across several therapeutic areas. CPIC also now provides additional resources to facilitate the implementation of pharmacogenetics into routine clinical practice and the electronic health record. Furthermore, since its inception, CPIC's interactions with other resources, databases, websites, and genomic communities have grown. The purpose of this paper is to highlight the progress of CPIC over the past 10 years.
© 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Year:  2019        PMID: 31562822      PMCID: PMC6925644          DOI: 10.1002/cpt.1651

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  35 in total

Review 1.  Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998.

Authors:  Jeremy Grimshaw; Martin Eccles; Ruth Thomas; Graeme MacLennan; Craig Ramsay; Cynthia Fraser; Luke Vale
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

Review 2.  Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.

Authors:  Victoria M Pratt; Larisa H Cavallari; Andria L Del Tredici; Houda Hachad; Yuan Ji; Ann M Moyer; Stuart A Scott; Michelle Whirl-Carrillo; Karen E Weck
Journal:  J Mol Diagn       Date:  2019-05-08       Impact factor: 5.568

3.  ClinVar at five years: Delivering on the promise.

Authors:  Melissa J Landrum; Brandi L Kattman
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

Review 4.  Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.

Authors:  Victoria M Pratt; Andria L Del Tredici; Houda Hachad; Yuan Ji; Lisa V Kalman; Stuart A Scott; Karen E Weck
Journal:  J Mol Diagn       Date:  2018-02-21       Impact factor: 5.568

Review 5.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.

Authors:  Stephen G Gonsalves; Robert T Dirksen; Katrin Sangkuhl; Rebecca Pulk; Maria Alvarellos; Teresa Vo; Keiko Hikino; Dan Roden; Teri E Klein; S Mark Poler; Sephalie Patel; Kelly E Caudle; Ronald Gordon; Barbara Brandom; Leslie G Biesecker
Journal:  Clin Pharmacol Ther       Date:  2019-01-24       Impact factor: 6.875

6.  Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.

Authors:  J K Hicks; K Sangkuhl; J J Swen; V L Ellingrod; D J Müller; K Shimoda; J R Bishop; E D Kharasch; T C Skaar; A Gaedigk; H M Dunnenberger; T E Klein; K E Caudle; J C Stingl
Journal:  Clin Pharmacol Ther       Date:  2017-02-13       Impact factor: 6.875

7.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.

Authors:  Y Saito; L K Stamp; K E Caudle; M S Hershfield; E M McDonagh; J T Callaghan; W Tassaneeyakul; T Mushiroda; N Kamatani; B R Goldspiel; E J Phillips; T E Klein; M T M Lee
Journal:  Clin Pharmacol Ther       Date:  2015-07-16       Impact factor: 6.875

8.  Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

Authors:  S A Scott; K Sangkuhl; C M Stein; J-S Hulot; J L Mega; D M Roden; T E Klein; M S Sabatine; J A Johnson; A R Shuldiner
Journal:  Clin Pharmacol Ther       Date:  2013-05-22       Impact factor: 6.875

9.  Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.

Authors:  Kelly E Caudle; Teri E Klein; James M Hoffman; Daniel J Muller; Michelle Whirl-Carrillo; Li Gong; Ellen M McDonagh; Katrin Sangkuhl; Caroline F Thorn; Matthias Schwab; Jose A G Agundez; Robert R Freimuth; Vojtech Huser; Ming Ta Michael Lee; Otito F Iwuchukwu; Kristine R Crews; Stuart A Scott; Mia Wadelius; Jesse J Swen; Rachel F Tyndale; C Michael Stein; Dan Roden; Mary V Relling; Marc S Williams; Samuel G Johnson
Journal:  Curr Drug Metab       Date:  2014-02       Impact factor: 3.731

10.  Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).

Authors:  Kelly E Caudle; Henry M Dunnenberger; Robert R Freimuth; Josh F Peterson; Jonathan D Burlison; Michelle Whirl-Carrillo; Stuart A Scott; Heidi L Rehm; Marc S Williams; Teri E Klein; Mary V Relling; James M Hoffman
Journal:  Genet Med       Date:  2016-07-21       Impact factor: 8.822

View more
  47 in total

1.  Knowledge and attitudes on pharmacogenetics among pediatricians.

Authors:  Shahad Rahawi; Hetanshi Naik; Kathryn V Blake; Aniwaa Owusu Obeng; Rachel M Wasserman; Yoshinori Seki; Vicky L Funanage; Kimihiko Oishi; Stuart A Scott
Journal:  J Hum Genet       Date:  2020-01-27       Impact factor: 3.172

2.  Advancing pharmacogenomics into practice.

Authors:  James M Hoffman; Kasey K Thompson; Daniel J Cobaugh
Journal:  Am J Health Syst Pharm       Date:  2022-04-01       Impact factor: 2.637

Review 3.  Keeping pace with CYP2D6 haplotype discovery: innovative methods to assign function.

Authors:  Karen E Brown; Jack W Staples; Erica L Woodahl
Journal:  Pharmacogenomics       Date:  2022-01-27       Impact factor: 2.533

Review 4.  Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children's Genomic Medicine Consortium.

Authors:  David Gregornik; Daria Salyakina; Marilyn Brown; Samuel Roiko; Kenneth Ramos
Journal:  Pharmacogenomics J       Date:  2020-08-26       Impact factor: 3.550

5.  Applying Pharmacogenomics to Antifungal Selection and Dosing: Are We There Yet?

Authors:  Matthew A Miller; Yee Ming Lee
Journal:  Curr Fungal Infect Rep       Date:  2020-01-16

Review 6.  PharmVar GeneFocus: CYP2C19.

Authors:  Mariana R Botton; Michelle Whirl-Carrillo; Andria L Del Tredici; Katrin Sangkuhl; Larisa H Cavallari; José A G Agúndez; Jorge Duconge; Ming Ta Michael Lee; Erica L Woodahl; Karla Claudio-Campos; Ann K Daly; Teri E Klein; Victoria M Pratt; Stuart A Scott; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2020-07-22       Impact factor: 6.875

7.  Adolescent perceptions of pharmacogenetic testing.

Authors:  Stephani L Stancil; Courtney Berrios; Susan Abdel-Rahman
Journal:  Pharmacogenomics       Date:  2021-04-14       Impact factor: 2.533

8.  Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.

Authors:  Kathleen M Giacomini; Jason H Karnes; Kristine R Crews; Andrew A Monte; William A Murphy; Akinyemi Oni-Orisan; Laura B Ramsey; Jun J Yang; Michelle Whirl-Carrillo
Journal:  Clin Pharmacol Ther       Date:  2021-07-28       Impact factor: 6.875

9.  Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.

Authors:  Sonam N Shah; Roseann S Gammal; Mary G Amato; Maryam Alobaidly; Dariel Delos Reyes; Sarah Hasan; Diane L Seger; Joel B Krier; David W Bates
Journal:  Drug Saf       Date:  2021-02-23       Impact factor: 5.606

10.  Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.

Authors:  S Sahana; Ambily Sivadas; Mohit Mangla; Abhinav Jain; Rahul C Bhoyar; Kavita Pandhare; Anushree Mishra; Disha Sharma; Mohamed Imran; Vigneshwar Senthivel; Mohit Kumar Divakar; Mercy Rophina; Bani Jolly; Arushi Batra; Sumit Sharma; Sanjay Siwach; Arun G Jadhao; Nikhil V Palande; Ganga Nath Jha; Nishat Ashrafi; Prashant Kumar Mishra; A K Vidhya; Suman Jain; Debasis Dash; Nachimuthu Senthil Kumar; Andrew Vanlallawma; Ranjan Jyoti Sarma; Lalchhandama Chhakchhuak; Shantaraman Kalyanaraman; Radha Mahadevan; Sunitha Kandasamy; Pabitha Devi; Raskin Erusan Rajagopal; J Ezhil Ramya; P Nirmala Devi; Anjali Bajaj; Vishu Gupta; Samatha Mathew; Sangam Goswami; Savinitha Prakash; Kandarp Joshi; Meya Kumla; S Sreedevi; Devarshi Gajjar; Ronibala Soraisham; Rohit Yadav; Yumnam Silla Devi; Aayush Gupta; Mitali Mukerji; Sivaprakash Ramalingam; B K Binukumar; Sridhar Sivasubbu; Vinod Scaria
Journal:  Pharmacogenomics       Date:  2021-06-18       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.